文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
T. D. Zvyagintseva
发表
Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis
M. Vieth, M. Stolte, I. Cascorbi, 2010, Inflammatory bowel diseases.
T1137 A Novel High Dose 1g Mesalamine Suppository (Salofalk®) Is As Efficacious As 500mg TID Suppositories in Mild to Moderate Active Ulcerative Proctitis: A Multicenter, Randomized Trial
A. Lavy, R. Greinwald, T. Andus, 2008 .